Member Spotlight: NanoDx, Inc.

Jan 21, 2025

Location: Southborough, MA / Cambridge, MA

Website: nanodiagnostics.com

Leadership: George J. Serafin, Mike Sampson

Therapeutic Area: Diagnostics

NanoDx™ is pioneering a first-of-its-kind nano biosensor platform to transform the assessment of traumatic brain injuries. NanoDx’s innovative design will allow healthcare providers to streamline their assessment process, resulting in more efficient and accurate care for patients. As development quickly nears completion, the NanoDx™ team is diligently preparing for the start of clinical trials. 2025 marks an exciting milestone as the NanoDx System is set to become commercially available, bringing innovative technology to medical diagnostics.

See all MassBio News